• Users Online: 59
  • Print this page
  • Email this page

  Article Access Statistics

Year : 2014 | Volume:  7 | Issue Number:  3 | Page:  317-331

REVIEW FOR THE SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES

Discovery of first-in-class therapeutics – venlafaxine (Effexor®), desvenlafaxine (Pristiq®), temsirolimus (Toresil®), ILS-920 and gemtuzumab ozogamicin (Mylotarg®)
Abou-Gharbia Magid

Number of times this article was viewed 444
Number of times this article has been printed  from the site 20
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0
Back To Article